a wide shot of a Greenhouse at GreenLight's NC facility
GreenLight Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results
28 mars 2023 17h05 HE | GreenLight Biosciences
Two agriculture solutions now under regulatory review, pending EPA approval: Calantha™, a solution to protect potatoes, and a separate solution to protect honeybees from Varroa miteUpdated clinical...
244A2750
GreenLight Biosciences Announces Third Quarter 2022 Financial Results and Highlights Recent Company Progress
09 nov. 2022 17h07 HE | GreenLight Biosciences
Working toward clinical trial initiation for COVID vaccine candidate in 2023Shingles vaccine candidate selection planned for 2023 in partnership with Serum Institute of IndiaCalantha™, Colorado potato...
title card for release
GreenLight Biosciences to Participate in Upcoming Investor Conferences in November
07 nov. 2022 11h25 HE | GreenLight Biosciences
BOSTON, Nov. 07, 2022 (GLOBE NEWSWIRE) -- GreenLight Biosciences (Nasdaq: GRNA), a public benefit corporation striving to deliver on the potential of RNA to address some of the world’s toughest...
Close-up of a Colorado potato beetle on a leaf
GreenLight Biosciences announces realignment to focus on near-term value drivers
12 oct. 2022 06h54 HE | GreenLight Biosciences
BOSTON, Oct. 12, 2022 (GLOBE NEWSWIRE) -- GreenLight Biosciences (Nasdaq: GRNA), a public benefit corporation striving to bring effective and safe solutions to make food clean and affordable for...
a fall armyworm on a leaf
GreenLight Biosciences and Queensland University of Technology partner to tackle destructive fall armyworm using RNA
05 oct. 2022 09h36 HE | GreenLight Biosciences
GreenLight Biosciences and Queensland University of Technology (QUT) partner to create a solution for fall armywormFall armyworm is one of the most destructive insect pests on the planet, causing more...
ARB20272
GreenLight Biosciences announces $109 million financing
12 août 2022 07h21 HE | GreenLight Biosciences
BOSTON, Aug. 12, 2022 (GLOBE NEWSWIRE) -- GreenLight Biosciences (Nasdaq: GRNA), a public benefit corporation striving to bring effective and safe solutions to make food clean and affordable for...
GLIGHT_224
GreenLight Biosciences and Samsung Biologics complete first commercial-scale engineering run for mRNA Covid-19 vaccine
01 août 2022 09h00 HE | GreenLight Biosciences
GreenLight’s messenger RNA production process is transferable to large-scale equipment and CMO facilities​Technology transfer and scale-up from lab bench to Samsung’s commercial facility was completed...
GLIGHT_070
NIH, GreenLight Biosciences to collaborate on COVID-19 vaccine development for new variants
29 juil. 2022 16h40 HE | GreenLight Biosciences
BOSTON, July 29, 2022 (GLOBE NEWSWIRE) -- GreenLight Biosciences has announced a collaboration with the National Institutes of Health (NIH) to develop COVID-19 vaccines that are more broadly...